CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, A. A.
Right arrow Articles by London, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, A. A.
Right arrow Articles by London, W. T.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 369-376, April 2002
© 2002 American Association for Cancer Research

Eight-Year Follow-Up of the 90,000-Person Haimen City Cohort: I. Hepatocellular Carcinoma Mortality, Risk Factors, and Gender Differences1

Alison A. Evans2, Gang Chen, Eric A. Ross, Fu-Min Shen, Wen-Yao Lin and W. Thomas London

Fox Chase Cancer Center, Philadelphia, Pennsylvania, Pennsylvania 19111 [A. A. E., G. C., E. A. R., W. T. L.]; Shanghai Medical University, Shanghai, People’s Republic of China [F. M. S.]; and Haimen City Anti-Epidemic Station, Haimen, People’s Republic of China [W. Y. L.]

In an 8-year follow-up of a prospective cohort study in Haimen City, China, we sought to identify hepatocellular carcinoma (HCC) risk factors in addition to hepatitis B virus (HBV) infection. Two cohorts of adults between ages 25 and 64 years at study entry were followed from 1992–1993 to 2000. The male cohort included 58,545 men, 15.0% of whom were HBV carriers. The female cohort included 25,340 women, 10.7% of whom were HBV carriers. 434,718 person-years of follow-up were accumulated, and 1092 deaths from HCC occurred. The relationship of potential risk factors measured at study entry to HCC mortality was analyzed using Cox proportional hazards models. For males, HCC mortality was significantly associated with HBV infection [relative risk (RR) 18.8; 95% confidence interval (CI), 15.7–22.5], history of acute hepatitis (RR, 2.3; 95% CI, 2.0–2.7), family history of HCC (RR, 2.3; 95% CI, 1.9–2.7), and occupation as a peasant (RR, 1.5; 95% CI, 1.3–1.8). For females, HCC mortality was significantly associated with HBV infection (RR, 33.5; 95% CI, 17.1–65.5) and acute hepatitis history (RR, 4.7; 95% CI, 3.0–7.5). HCC risk was not significantly associated with alcohol consumption, water source, or staple foods in either sex. There was no association with smoking in males, but there was a positive association for females. Environmental and genetic risk factors besides HBV infection play a significant role in HCC mortality in this extremely high-risk population. Gender differences in HCC mortality and known risk factors are substantial and warrant further study. Identification of risk factors amenable to intervention should be a high priority in the prevention of HCC.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. M. Wang, L. L. P.J. Ooi, and K. M. Hui
Identification and Validation of a Novel Gene Signature Associated with the Recurrence of Human Hepatocellular Carcinoma
Clin. Cancer Res., November 1, 2007; 13(21): 6275 - 6283.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. M. Welzel, H. A. Katki, L. C. Sakoda, A. A. Evans, W. T. London, G. Chen, S. O'Broin, F.-M. Shen, W.-Y. Lin, and K. A. McGlynn
Blood Folate Levels and Risk of Liver Damage and Hepatocellular Carcinoma in a Prospective High-Risk Cohort
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1279 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
G. Chen, W. Lin, F. Shen, U. H Iloeje, W T. London, and A. A Evans
Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study
Int. J. Epidemiol., February 1, 2005; 34(1): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Vineis, M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y. T. Gao, P. C. Gupta, A. Hackshaw, E. Matos, J. Samet, et al.
Tobacco and Cancer: Recent Epidemiological Evidence
J Natl Cancer Inst, January 21, 2004; 96(2): 99 - 106.
[Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. McGlynn, K. Hunter, T. LeVoyer, J. Roush, P. Wise, R. A. Michielli, F.-M. Shen, A. A. Evans, W. T. London, and K. H. Buetow
Susceptibility to Aflatoxin B1-related Primary Hepatocellular Carcinoma in Mice and Humans
Cancer Res., August 1, 2003; 63(15): 4594 - 4601.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.